{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T14:33:23Z","timestamp":1783607603758,"version":"3.55.0"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,8]],"date-time":"2024-01-08T00:00:00Z","timestamp":1704672000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100021976","name":"Medical Technology Enterprise Consortium","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100021976","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007680","name":"Naval Medical Research Command","doi-asserted-by":"publisher","award":["MT20002.002"],"award-info":[{"award-number":["MT20002.002"]}],"id":[{"id":"10.13039\/100007680","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eClinicalMedicine"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.eclinm.2024.102430","type":"journal-article","created":{"date-parts":[[2024,1,30]],"date-time":"2024-01-30T00:26:25Z","timestamp":1706574385000},"page":"102430","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Efficacy and safety of phospholipid nanoparticles (VBI-S) in reversing intractable hypotension in patients with septic shock: a multicentre, open-label, repeated measures, phase 2a clinical pilot trial"],"prefix":"10.1016","volume":"68","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4878-4572","authenticated-orcid":false,"given":"Cuthbert","family":"Simpkins","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Moncure","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather","family":"Klepacz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristopher","family":"Roach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadia","family":"Benzaquen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Diaz-Caballero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Haase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mukesh","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harven","family":"DeShield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Manasia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0664-9746","authenticated-orcid":false,"given":"Prashanth","family":"Anamthathmakula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nik","family":"Hurt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhaswati","family":"Mukherjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krishna","family":"Talluri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.eclinm.2024.102430_bib1","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.3390\/toxins5122589","article-title":"Towards clinical applications of anti-endotoxin antibodies; a reappraisal of the disconnect","volume":"5","author":"Hurley","year":"2013","journal-title":"Toxins"},{"issue":"12","key":"10.1016\/j.eclinm.2024.102430_bib2","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1001\/jama.1995.03520360048038","article-title":"Efficacy and safety of monoclonal antibody to human tumor necrosis factor \u03b1 in patients with sepsis syndrome: a randomized, controlled, double-blind multicenter clinical trial","volume":"273","author":"Abraham","year":"1995","journal-title":"JAMA"},{"key":"10.1016\/j.eclinm.2024.102430_bib3","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1097\/00003246-199707000-00010","article-title":"Confirmatory interleukin-1 receptor antagonist trial in severe sepsis: a phase III, randomized, double-blind, placebo-controlled, multicenter trial. The interleukin-1 receptor Antagonist Sepsis Investigator Group","volume":"25","author":"Opal","year":"1997","journal-title":"Crit Care Med"},{"issue":"4","key":"10.1016\/j.eclinm.2024.102430_bib5","article-title":"Outcomes of extracorporeal membrane oxygenation in patients with blood culture positive septic","volume":"158","author":"Blazoski","year":"2020","journal-title":"Cardiovasc Dis"},{"issue":"7","key":"10.1016\/j.eclinm.2024.102430_bib6","doi-asserted-by":"crossref","first-page":"488","DOI":"10.21037\/atm.2020.03.48","article-title":"The therapeutic effect of high-volume hemofiltration on sepsis: a systematic review and meta-analysis","volume":"8","author":"Yin","year":"2020","journal-title":"Ann Transl Med"},{"issue":"8","key":"10.1016\/j.eclinm.2024.102430_bib7","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1007\/s00134-002-1375-6","article-title":"Short-term cardiovascular effects of plasmapheresis in norepinephrine-refractory septic shock","volume":"28","author":"Ataman","year":"2002","journal-title":"Intens Care Med"},{"issue":"19","key":"10.1016\/j.eclinm.2024.102430_bib8","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1056\/NEJMoa010307","article-title":"Early goal-directed therapy in the treatment of severe sepsis and septic shock","volume":"345","author":"Rivers","year":"2001","journal-title":"N\u00a0Engl J Med"},{"issue":"2\u20133","key":"10.1016\/j.eclinm.2024.102430_bib9","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0005-2728(99)00031-6","article-title":"Nitric oxide in septic shock","volume":"1411","author":"Titheradge","year":"1999","journal-title":"Biochim Biophys Acta Bioenerg"},{"issue":"6","key":"10.1016\/j.eclinm.2024.102430_bib10","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1186\/cc1822","article-title":"Clinical review: myocardial depression in sepsis and septic shock","volume":"6","author":"Court","year":"2002","journal-title":"Crit Care"},{"issue":"supplement 2","key":"10.1016\/j.eclinm.2024.102430_bib11","doi-asserted-by":"crossref","first-page":"S162","DOI":"10.1093\/clinids\/21.Supplement_2.S162","article-title":"NO inhibitions: antimicrobial properties of nitric oxide","volume":"21","author":"De Groote","year":"1995","journal-title":"Clin Infect Dis"},{"issue":"1\u20133","key":"10.1016\/j.eclinm.2024.102430_bib12","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0079-6107(03)00006-3","article-title":"Nitric-oxide-mediated regulation of cardiac contractility and stretch responses","volume":"82","author":"Casadei","year":"2003","journal-title":"Prog Biophys Mol Biol"},{"issue":"5","key":"10.1016\/j.eclinm.2024.102430_bib13","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1161\/01.CIR.89.5.2070","article-title":"Acute effects of nitric oxide on left ventricular relaxation and diastolic distensibility in humans. Assessment by bicoronary sodium nitroprusside infusion","volume":"89","author":"Paulus","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/j.eclinm.2024.102430_bib14","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.niox.2019.04.005","article-title":"The effect of nitric oxide on mitochondrial respiration","volume":"88","author":"Poderoso","year":"2019","journal-title":"Nitric Oxide"},{"issue":"1","key":"10.1016\/j.eclinm.2024.102430_bib15","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0163-7258(99)00072-8","article-title":"Paracrine and autocrine effects of nitric oxide on myocardial function","volume":"86","author":"Shah","year":"2000","journal-title":"Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.eclinm.2024.102430_bib16","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/01.CCM.0000105581.01815.C6","article-title":"Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: effect on survival in patients with septic shock","volume":"32","author":"L\u00f3pez","year":"2004","journal-title":"Crit Care Med"},{"issue":"9","key":"10.1016\/j.eclinm.2024.102430_bib17","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1111\/j.1440-1681.2009.05204.x","article-title":"Effects of 1400W and\/or nitroglycerin on renal oxygenation and kidney function during endotoxaemia in anaesthetized rats","volume":"36","author":"Johannes","year":"2009","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"2","key":"10.1016\/j.eclinm.2024.102430_bib18","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/S0039-6060(99)70189-3","article-title":"Inducible nitric oxide synthase (iNOS) gene deficiency increases the mortality of sepsis in mice","volume":"126","author":"Cobb","year":"1999","journal-title":"Surgery"},{"issue":"2","key":"10.1016\/j.eclinm.2024.102430_bib19","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.chest.2022.09.021","article-title":"High dose IV hydroxocobalamin (Vitamin B12) in septic shock","volume":"163","author":"Patel","year":"2022","journal-title":"Chest"},{"issue":"8 Pt B","key":"10.1016\/j.eclinm.2024.102430_bib20","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1053\/j.jvca.2022.01.021","article-title":"Predicting the response of hydroxocobalamin in postoperative vasoplegia in recipients of cardiopulmonary bypass","volume":"36","author":"Vollmer","year":"2022","journal-title":"J\u00a0Cardiothorac Vasc Anesth"},{"issue":"4","key":"10.1016\/j.eclinm.2024.102430_bib21","article-title":"The durability of intravenous hydroxocobalamin in vasoplegia","volume":"15","author":"Blaha","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.eclinm.2024.102430_bib22","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1186\/s13054-019-2706-0","article-title":"Association between hydroxocobalamin administration and acute kidney injury after smoke inhalation: a multicenter retrospective study","volume":"23","author":"D\u00e9pret","year":"2019","journal-title":"Crit Care"},{"key":"10.1016\/j.eclinm.2024.102430_bib23","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/nrneph.2017.110","article-title":"Intravenous hydroxocobalamin and crystal nephropathy","volume":"13","author":"Legrand","year":"2017","journal-title":"Nat Rev Nephrol"},{"issue":"5","key":"10.1016\/j.eclinm.2024.102430_bib24","first-page":"231","article-title":"Outcomes after the administration of hydroxocobalamin","volume":"10","author":"Pruskowski","year":"2020","journal-title":"Int J Burns Trauma"},{"issue":"1","key":"10.1016\/j.eclinm.2024.102430_bib25","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.clnu.2011.08.010","article-title":"Increased vitamin B12 levels are associated with mortality in critically ill medical patients","volume":"31","author":"Sviri","year":"2012","journal-title":"Clin Nutr"},{"issue":"1820","key":"10.1016\/j.eclinm.2024.102430_bib26","article-title":"Methylene blue administration in patients with refractory distributive shock \u2013 a retrospective study","volume":"10","author":"Porizka","year":"2020","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.eclinm.2024.102430_bib27","doi-asserted-by":"crossref","first-page":"517","DOI":"10.4103\/0970-9185.74599","article-title":"Methylene blue: revisited","volume":"26","author":"Ginimuge","year":"2010","journal-title":"J\u00a0Anaesthesiol Clin Pharmacol"},{"issue":"8","key":"10.1016\/j.eclinm.2024.102430_bib28","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1111\/j.1365-2044.2009.06029.x","article-title":"Small doses of methylene blue, previously considered safe, can precipitate serotonin toxicity","volume":"64","author":"Schwiebert","year":"2009","journal-title":"Anesthesia"},{"issue":"4","key":"10.1016\/j.eclinm.2024.102430_bib29","doi-asserted-by":"crossref","first-page":"543","DOI":"10.4103\/0975-7406.90112","article-title":"Blue cures blue but be cautious","volume":"3","author":"Sikka","year":"2011","journal-title":"J\u00a0Pharm Bioallied Sci"},{"issue":"5","key":"10.1016\/j.eclinm.2024.102430_bib30","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.ejcts.2005.07.011","article-title":"Vasoplegia syndrome- the role of methylene blue","volume":"28","author":"Shanmugam","year":"2005","journal-title":"Eur J Cardio Thorac Surg"},{"key":"10.1016\/j.eclinm.2024.102430_bib31","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1097\/ALN.0b013e3181684be4","article-title":"Adverse effects of methylene blue on the central nervous system","volume":"108","author":"Vutskits","year":"2008","journal-title":"Anesthesiology"},{"issue":"6","key":"10.1016\/j.eclinm.2024.102430_bib32","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1053\/j.jvca.2013.02.026","article-title":"Methylene blue is associated with poor outcomes in vasoplegic shock","volume":"27","author":"Weiner","year":"2013","journal-title":"J\u00a0Cardiothorac Vasc Anesth"},{"issue":"23","key":"10.1016\/j.eclinm.2024.102430_bib33","doi-asserted-by":"crossref","first-page":"4561","DOI":"10.1007\/s00018-015-2021-0","article-title":"Endothelial nitric oxide synthase in the microcirculation","volume":"72","author":"Shu","year":"2015","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.eclinm.2024.102430_bib34","doi-asserted-by":"crossref","DOI":"10.14814\/phy2.15303","article-title":"Functional implications of microvascular heterogeneity for oxygen uptake and utilization","volume":"10","author":"Roy","year":"2022","journal-title":"Physiol Rep"},{"issue":"1","key":"10.1016\/j.eclinm.2024.102430_bib35","doi-asserted-by":"crossref","first-page":"H156","DOI":"10.1152\/ajpheart.2002.282.1.H156","article-title":"Effect of a maldistribution of microvascular blood flow on capillary O(2) extraction in sepsis","volume":"282","author":"Ellis","year":"2002","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"19","key":"10.1016\/j.eclinm.2024.102430_bib36","first-page":"4569","article-title":"Is the sympathetic system detrimental in the setting of septic shock, with antihypertensive agents as a counterintuitive approach? A clinical proposition","volume":"10","author":"Petitjeans","year":"2021","journal-title":"J\u00a0Clin Med"},{"issue":"1","key":"10.1016\/j.eclinm.2024.102430_bib37","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-72008-4","article-title":"Sympathetic nerves control bacterial clearance","volume":"10","author":"Lankadeva","year":"2020","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/j.eclinm.2024.102430_bib38","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1177\/0267659112469643","article-title":"Soybean oil: a potentially new intravascular perfusate","volume":"28","author":"Armbruster","year":"2013","journal-title":"Perfusion"},{"key":"10.1016\/j.eclinm.2024.102430_bib39","doi-asserted-by":"crossref","first-page":"253","DOI":"10.7205\/MILMED-D-15-00206","article-title":"Intra-arterial perimortem resuscitation using a micellar colloid","volume":"181","author":"Simpkins","year":"2016","journal-title":"Mil Med"},{"issue":"19","key":"10.1016\/j.eclinm.2024.102430_bib40","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/j.jchromb.2011.03.041","article-title":"Quantitation of dissolved gas content in emulsions and in blood using mass spectrometric detection","volume":"879","author":"Grimley","year":"2011","journal-title":"J\u00a0Chromatogr B Analyt Technol Biomed Life Sci"},{"issue":"3","key":"10.1016\/j.eclinm.2024.102430_bib41","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.clnu.2007.02.001","article-title":"Effect of different lipid emulsions on the immunological function in humans: a systematic review with meta-analysis","volume":"26","author":"Wirtitsch","year":"2007","journal-title":"Clin Nutr"},{"issue":"4","key":"10.1016\/j.eclinm.2024.102430_bib42","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1097\/ALN.0b013e3182655e73","article-title":"Intralipid, a clinically safe compound, protects the heart against ischemia-reperfusion injury more efficiently than cyclosporine-A","volume":"117","author":"Li","year":"2012","journal-title":"Anesthesiology"},{"issue":"1","key":"10.1016\/j.eclinm.2024.102430_bib43","first-page":"35","article-title":"The effects of short-term intravenous infusion of a soybean based lipid emulsion on some blood constituents in sheep: a preliminary study","volume":"5","author":"Akbari","year":"2014","journal-title":"Vet Res Forum"},{"issue":"2","key":"10.1016\/j.eclinm.2024.102430_bib44","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1742-6723.2011.01398.x","article-title":"Intravenous lipid emulsion as antidote: a summary of published human experience","volume":"23","author":"Cave","year":"2011","journal-title":"Emerg Med Australas"},{"key":"10.1016\/j.eclinm.2024.102430_bib45","article-title":"Lipid emulsion for local anesthetic systemic toxicity","volume":"2012","author":"Ciechanowicz","year":"2011","journal-title":"Anesthesiol Res Pract"},{"issue":"2","key":"10.1016\/j.eclinm.2024.102430_bib46","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1097\/AAP.0b013e3181c6f5aa","article-title":"Safety of high-volume lipid emulsion infusion: a first approximation of ld50 in rats","volume":"35","author":"Hiller","year":"2010","journal-title":"Reg Anesth Pain Med"},{"issue":"4","key":"10.1016\/j.eclinm.2024.102430_bib47","doi-asserted-by":"crossref","first-page":"393","DOI":"10.3109\/15563651003670843","article-title":"Iatrogenic lipid emulsion overdose in a case of amlodipine poisoning","volume":"48","author":"West","year":"2010","journal-title":"Clin Tox"},{"issue":"Suppl 1","key":"10.1016\/j.eclinm.2024.102430_bib48","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.21037\/jtd.2019.12.84","article-title":"Fluid resuscitation in sepsis: the great 30 mL per kg hoax","volume":"12","author":"Marik","year":"2020","journal-title":"J Thorac Dis"},{"issue":"3","key":"10.1016\/j.eclinm.2024.102430_bib49","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1053\/j.ackd.2021.02.003","article-title":"Inferior vena cava collapsibility index: clinical validation and application for assessment of relative intravascular volume","volume":"28","author":"Kaptein","year":"2021","journal-title":"Adv Chronic Kidney Dis"},{"issue":"11","key":"10.1016\/j.eclinm.2024.102430_bib50","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1093\/ckj\/sfad156","article-title":"Inferior vena cava ultrasound and other techniques for assessment of intravascular and extravascular volume: an update","volume":"16","author":"Kaptein","year":"2023","journal-title":"Clinical Kidney Journal"},{"issue":"1","key":"10.1016\/j.eclinm.2024.102430_bib51","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1186\/s13054-017-1798-7","article-title":"Selepressin, a novel selective vasopressin V1A agonist, is an effective substitute for norepinephrine in a phase IIa randomized, placebo-controlled trial in septic shock patients","volume":"21","author":"Russell","year":"2017","journal-title":"Crit Care"},{"issue":"6","key":"10.1016\/j.eclinm.2024.102430_bib52","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1016\/0360-3016(89)90967-X","article-title":"Phase I\/II study of Fluosol-DA and 100% oxygen as an adjuvant to radiation in the treatment of advanced squamous cell tumors of the head and neck","volume":"16","author":"Lustig","year":"1989","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"11","key":"10.1016\/j.eclinm.2024.102430_bib53","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1097\/00003246-199011000-00008","article-title":"Fluosol DA-20 in the treatment of severe anemia: randomized, controlled study of 46 patients","volume":"18","author":"Spence","year":"1990","journal-title":"Crit Care Med"},{"issue":"3","key":"10.1016\/j.eclinm.2024.102430_bib54","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/BF01704717","article-title":"Low molecular weight hydroxyethyl starch 6% compared to albumin 4% during intentional hemodilution","volume":"17","author":"Baron","year":"1991","journal-title":"Intens Care Med"},{"issue":"5","key":"10.1016\/j.eclinm.2024.102430_bib55","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.jpainsymman.2016.12.333","article-title":"Intensity of vasopressor therapy for septic shock and the risk of in-hospital death","volume":"53","author":"Brand","year":"2017","journal-title":"J\u00a0Pain Symptom Manage"},{"issue":"Suppl. 2","key":"10.1016\/j.eclinm.2024.102430_bib56","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1186\/cc2832","article-title":"Scope of the problem: epidemiology of anemia and use of blood transfusions in critical care","volume":"8","author":"Napolitano","year":"2004","journal-title":"Crit Care"},{"issue":"14","key":"10.1016\/j.eclinm.2024.102430_bib57","doi-asserted-by":"crossref","first-page":"3494","DOI":"10.3390\/ijms20143494","article-title":"Platelets are critical key players in sepsis","volume":"20","author":"Vardon-Bounes","year":"2019","journal-title":"Int J Mol Sci"},{"issue":"4","key":"10.1016\/j.eclinm.2024.102430_bib58","first-page":"507","article-title":"Evidence that carbon monoxide is a mediator of critical illness","volume":"40","author":"Hunter","year":"1994","journal-title":"Cell Mol Biol"},{"key":"10.1016\/j.eclinm.2024.102430_bib59","first-page":"208","article-title":"Potential role of hydrogen sulphide in the pathogeneis of vascular dysfunction in septic shock","volume":"11","author":"Coletta","year":"2013","journal-title":"Curr Vasc Pharmacol"}],"container-title":["eClinicalMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537024000099?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537024000099?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,10]],"date-time":"2024-10-10T23:10:58Z","timestamp":1728601858000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589537024000099"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":58,"alternative-id":["S2589537024000099"],"URL":"https:\/\/doi.org\/10.1016\/j.eclinm.2024.102430","relation":{},"ISSN":["2589-5370"],"issn-type":[{"value":"2589-5370","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and safety of phospholipid nanoparticles (VBI-S) in reversing intractable hypotension in patients with septic shock: a multicentre, open-label, repeated measures, phase 2a clinical pilot trial","name":"articletitle","label":"Article Title"},{"value":"eClinicalMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eclinm.2024.102430","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102430"}}